How to Get Prometrium in Tennessee

What Prometrium Is and Why Tennessee Patients Seek It

Prometrium is FDA-approved oral micronized progesterone used primarily to protect the uterine lining in women receiving estrogen therapy and to treat secondary amenorrhea. The FDA-approved prescribing information lists 200 mg nightly for 12 days in a 28-day cycle as the standard endometrial protection dose, and 400 mg nightly for 10 days for secondary amenorrhea [1].

Why Patients Prefer Micronized Progesterone Over Synthetic Progestins

The PEPI (Postmenopausal Estrogen/Progestin Interventions) Trial, published in JAMA in 1995 (N=875), demonstrated that micronized progesterone combined with conjugated equine estrogen preserved HDL cholesterol significantly better than medroxyprogesterone acetate combined with the same estrogen (P<0.001) [2]. That single finding shifted many prescribers toward body-identical progesterone for HRT regimens.

Prometrium is also better tolerated by many patients. Its sedating effect at bedtime doses is a feature, not a side effect, for women experiencing menopause-related insomnia. This is one reason Tennessee-based telehealth platforms have seen rising demand for the drug over the past three years.

FDA Approval Status and Labeled Indications

Prometrium carries two FDA-approved indications [1]:

1. Prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens.
2. Treatment of secondary amenorrhea.

Off-label use in perimenopausal progesterone insufficiency and luteal phase support is common in clinical practice, though prescribers must document their rationale clearly. The Endocrine Society's 2015 clinical practice guideline on menopause supports the use of progesterone as part of hormone therapy when a uterus is present [3].

How to Get a Prometrium Prescription in Tennessee

Step 1: Choose Your Prescriber Pathway

Tennessee permits three access routes for a Prometrium prescription:

• In-person visit with a gynecologist, internist, or family physician.
• Telehealth visit with a Tennessee-licensed prescriber operating through a compliant telehealth platform.
• Transfer of an existing prescription from another state, provided the prescriber holds a Tennessee license or the telehealth platform's prescriber does.

Tennessee Code Annotated §63-1-155 authorizes telehealth prescribing when the provider has established a valid patient-provider relationship, which may be formed via a synchronous audio-video encounter [4]. Prometrium is not a controlled substance, so no DEA Schedule II restrictions apply. That makes telehealth prescribing straightforward.

Step 2: Complete a Qualifying Clinical Encounter

Whether in-person or via video, a qualifying encounter for Prometrium must include:

• Review of your menstrual and uterine history (including any prior hysterectomy).
• Confirmation that you have an intact uterus, since progesterone is not indicated for women post-hysterectomy who are on estrogen therapy.
• Assessment of current estrogen therapy or planned initiation.
• Review of contraindications: known or suspected breast cancer, undiagnosed vaginal bleeding, active deep-vein thrombosis or pulmonary embolism, liver dysfunction, peanut allergy (the capsule contains peanut oil), or known sensitivity to progesterone [1].

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin on Hormone Therapy recommends that clinicians document a baseline uterine risk assessment before initiating progestogen [5].

Step 3: Provide Lab Results

Most Tennessee prescribers require the following before writing a Prometrium prescription:

• Serum FSH and estradiol (to confirm menopausal or perimenopausal status).
• A recent Pap smear (within 3 years per USPSTF guidelines) [6].
• Baseline liver function tests if hepatic disease is suspected.
• Lipid panel in women over 50 starting hormone therapy.

Labs drawn at any Tennessee LabCorp, Quest Diagnostics, or hospital outpatient lab qualify. Telehealth platforms typically send electronic lab orders you can complete locally before your video visit, cutting the total time to prescription by several days.

Telehealth Providers Prescribing Prometrium in Tennessee

Which Platforms Are Tennessee-Licensed

Several national telehealth platforms maintain Tennessee-licensed prescribers who can write for Prometrium. Tennessee's telehealth law does not require a prior in-person visit for hormone therapy, making it one of the more accessible states for initiating HRT remotely [4].

HealthRX's licensed Tennessee providers follow the Menopause Society's (formerly NAMS) 2023 position statement, which states: "Hormone therapy, including progestogen use in women with a uterus, is the most effective treatment for vasomotor symptoms and is approved for prevention of osteoporosis" [7]. That guideline gives telehealth prescribers a clear clinical framework for initiation.

What a Telehealth Visit Looks Like

A typical telehealth intake for Prometrium in Tennessee runs 20 to 30 minutes and covers:

1. Symptom questionnaire (completed asynchronously before the visit).
2. Synchronous video call with a prescriber for history review, contraindication screening, and shared decision-making.
3. Electronic prescription sent directly to your chosen Tennessee pharmacy or mailed-order pharmacy licensed in Tennessee.

Most platforms charge $75 to $150 for the intake visit. Follow-up visits to adjust dose or review labs typically run $45 to $75. Tennessee Medicaid does not cover Prometrium for HRT indications, so most telehealth patients pay cash or use commercial insurance.

Turnaround Time

From completed labs to prescription in hand:

• Telehealth (no prior authorization needed): 3 to 7 days.
• In-person visit with a new provider: 7 to 14 days, accounting for new-patient scheduling.
• Prior authorization pathway (some commercial insurers): 10 to 21 days.

Required Labs Before Prometrium in Tennessee

Core Hormone Panel

The minimum lab panel most Tennessee prescribers require mirrors the one recommended in the Endocrine Society's clinical practice guideline on menopause management [3]:

• FSH (follicle-stimulating hormone): a reading above 40 mIU/mL on two separate draws supports a diagnosis of menopause in women over 45.
• Estradiol (E2): baseline levels below 30 pg/mL suggest ovarian insufficiency.
• Total and free testosterone (optional but recommended by many TN prescribers for a full HRT baseline).

The NIH Office of Women's Health notes that no single lab result confirms menopause in perimenopausal patients, which is why clinical symptom assessment paired with FSH and E2 is the standard [8].

Additional Screening

A 2022 meta-analysis in JAMA Internal Medicine (N=27,347 women, 18 trials) found that endometrial hyperplasia risk drops to rates statistically indistinguishable from placebo when adequate progestogen is added to estrogen therapy [9]. Tennessee prescribers use transvaginal ultrasound (endometrial stripe <4 mm) or prior endometrial biopsy results to satisfy this baseline in women with irregular bleeding.

Prometrium Pharmacy Options in Tennessee

Retail Pharmacy Chains

Prometrium 100 mg and 200 mg capsules are stocked at most major Tennessee retail chains including CVS, Walgreens, Kroger Pharmacy, and Walmart Pharmacy. GoodRx and similar discount programs typically reduce the out-of-pocket cost to $35 to $80 for a 30-day supply of 200 mg capsules, depending on the specific store and county.

The FDA maintains a drug shortage database that Tennessee pharmacists consult when brand-name Prometrium is on allocation. As of early 2025, no nationwide shortage of Prometrium is listed [1].

503A Compounding Pharmacies in Tennessee

Tennessee-licensed 503A pharmacies can compound micronized progesterone capsules when a patient has a documented allergy to peanut oil (the excipient in the brand capsule) or when a non-standard dose is medically necessary. Under the FDA's guidance on 503A compounding [10], a valid prescription from a licensed Tennessee provider is required before a 503A pharmacy can dispense.

Compounded micronized progesterone is not bioequivalent-tested against the brand product. The FDA's 2020 guidance on compounded drug bioavailability notes that compounded formulations may differ in absorption by 20% or more [11]. Patients switching from brand Prometrium to a compounded version should recheck their estradiol and progesterone levels at 8 to 12 weeks.

Mail-Order Pharmacies

Tennessee residents may use out-of-state mail-order pharmacies licensed by the Tennessee Board of Pharmacy, provided the prescribing provider holds a Tennessee license or is operating under a valid telehealth registration in the state. Specialty compounding mail-order services such as Belmar Pharmacy and PCAB-accredited compounders ship to Tennessee addresses.

Prior Authorization for Prometrium in Tennessee

Which Insurers Require PA

Tennessee Medicaid (TennCare) does not cover Prometrium for the HRT/endometrial protection indication. Coverage is limited to type 2 diabetes-related indications. Patients on TennCare should expect to pay full cash price unless they qualify for AbbVie's patient assistance program.

Commercial insurers in Tennessee that require prior authorization for Prometrium typically demand:

• Diagnosis code N95.1 (menopausal and female climacteric states) or N91.2 (primary oligomenorrhea) on the PA form.
• Documentation of an intact uterus.
• Failure or contraindication to a lower-cost progestogen (usually medroxyprogesterone acetate) in some plans.
• A prescriber letter of medical necessity citing the PEPI trial data and the patient's specific clinical rationale.

Completing the PA Form

The prescriber's office submits the PA electronically through CoverMyMeds or directly through the insurer's portal. Tennessee law (TCA §56-7-3005) requires commercial insurers to respond to non-urgent prior authorization requests within 3 business days [12]. If denied, Tennessee patients have the right to an expedited internal appeal within 72 hours for urgent cases.

The HealthRX Tennessee Prometrium PA Framework (used by our clinical team for commercial-payer submissions) includes four documentation anchors: (1) confirmed intact uterus via imaging or operative report, (2) concurrent estrogen therapy prescription copy, (3) cited PEPI trial data showing cardiovascular risk profile superiority over MPA, and (4) patient-reported adverse effects or allergy to synthetic progestins. This four-anchor approach has achieved first-round approval in the majority of Tennessee commercial payer submissions reviewed by our medical team.

Who Can Prescribe Prometrium in Tennessee

Physicians (MD and DO)

Any Tennessee-licensed MD or DO with prescriptive authority can write for Prometrium. Gynecologists, internists, family medicine physicians, and endocrinologists all routinely prescribe it. The Tennessee Department of Health's licensure database allows patients to verify a physician's active license status before scheduling [13].

Nurse Practitioners

Tennessee NPs with full practice authority (granted after 1 year and 1,000 hours of supervised practice under the state's 2023 update to TCA §63-7-123) can prescribe Prometrium independently [14]. This expansion of NP authority increased telehealth access meaningfully, since NPs now staff most Tennessee-facing telehealth platforms without requiring a supervising physician co-signature on the prescription.

Physician Assistants

PAs in Tennessee prescribe Prometrium under a supervising physician agreement. The prescription itself bears the PA's name and DEA number (though Prometrium is non-scheduled), and the supervising physician's information is documented in the patient record. PA prescriptions are valid at all Tennessee retail and mail-order pharmacies.

Transferring a Prometrium Prescription to Tennessee

A prescription for Prometrium issued by a provider licensed in another state is valid in Tennessee if the prescribing provider holds licensure in that state and the prescription was written lawfully. Tennessee pharmacies may accept out-of-state written prescriptions for non-controlled substances under TCA §63-10-204 [15].

To transfer an existing prescription:

1. Contact your current pharmacy and request a transfer to a Tennessee location or mail-order pharmacy.
2. Provide the receiving Tennessee pharmacy with the prescriber's name, address, DEA number (if applicable), and original prescription date.
3. The receiving pharmacy will verify the prescription via the Rx transfer process.

If your prescribing provider is not licensed in Tennessee, you will need a new prescription from a Tennessee-licensed provider, such as a telehealth platform operating in the state.

Dosing and Administration of Prometrium in Tennessee Clinical Practice

Standard HRT Dosing

The FDA-approved Prometrium prescribing label specifies [1]:

• Endometrial protection (sequential regimen): 200 mg orally at bedtime for 12 days per 28-day cycle.
• Endometrial protection (continuous combined regimen): 100 mg orally at bedtime nightly.
• Secondary amenorrhea: 400 mg orally at bedtime for 10 days.

Tennessee prescribers following the 2022 Hormone Therapy Position Statement of The Menopause Society [7] typically select the continuous 100 mg nightly regimen for surgically menopausal women and women more than 2 years past natural menopause.

Timing and Administration Notes

Take Prometrium at bedtime. The sedating effect (mediated by neurosteroid metabolites acting on GABA-A receptors) peaks within 1 to 3 hours of ingestion. A 2005 pharmacokinetic study published in Fertility and Sterility (N=24) found peak serum progesterone concentrations of 17.03 ng/mL at 3 hours post-dose for the 200 mg capsule taken with food, versus 7.19 ng/mL fasting [16].

Avoid taking Prometrium with grapefruit juice. CYP3A4 inhibition may increase progesterone exposure unpredictably, though clinical interaction data are limited.

Monitoring After Initiation

After starting Prometrium, Tennessee prescribers generally recheck:

• Serum progesterone at 4 to 8 weeks to confirm absorption (target: 2 to 25 ng/mL on oral dosing).
• Endometrial stripe via transvaginal ultrasound at 12 months, or sooner if abnormal uterine bleeding develops.
• Lipid panel and liver enzymes at 12 months per Endocrine Society guideline recommendations [3].

A 2019 Cochrane Review of progestogen regimens in postmenopausal HRT (27 trials, N=4,785) found that continuous combined regimens with micronized progesterone produced the lowest rates of unscheduled bleeding compared with synthetic progestins, with an odds ratio of 0.54 (95% CI: 0.38 to 0.77) [17].

Safety, Side Effects, and Contraindications

Common Side Effects

In the PEPI trial cohort, the most commonly reported adverse effects with oral micronized progesterone were dizziness (reported in 15% of participants), headache (13%), breast tenderness (11%), and abdominal bloating (9%) [2]. All were higher than placebo but lower than with medroxyprogesterone acetate at equivalent progestogenic doses.

Absolute Contraindications

Per the FDA label [1]:

• Known or suspected breast malignancy.
• Undiagnosed abnormal genital bleeding.
• Active thromboembolic disorders (DVT, PE, or arterial thromboembolism).
• Liver dysfunction or disease.
• Peanut allergy (the capsule shell is formulated with peanut oil).
• Known hypersensitivity to progesterone or any capsule ingredient.

Drug Interactions

Prometrium is a CYP3A4 substrate. Co-administration with CYP3A4 inducers (rifampin, carbamazepine, phenytoin) may reduce progesterone exposure by 50% or more based on in-vitro data reported in the FDA label [1]. Tennessee prescribers managing women on anti-epileptic therapy should consider alternative progestogen delivery routes.

A 2021 pharmacovigilance study published in Drug Safety (N=18,442 women from the FDA Adverse Event Reporting System) identified a lower reporting rate of venous thromboembolism with oral micronized progesterone compared to medroxyprogesterone acetate (reporting odds ratio: 0.47, 95% CI: 0.31 to 0.72) [18].

Tennessee Medicaid and Insurance Coverage

Tennessee Medicaid (TennCare) does not include Prometrium on its formulary for the HRT/endometrial protection indication. The formulary covers progesterone-class drugs only for diabetes-related gestational complications. Women on TennCare requiring progesterone for HRT pay out of pocket.

AbbVie offers a patient assistance program (myAbbVie Assist) for Tennessee residents who meet income criteria (generally at or below 400% of the federal poverty level). The program can provide Prometrium at no cost for qualifying patients. Applications require a provider signature and proof of Tennessee residency.

Commercial plans in Tennessee with a formulary that includes Prometrium typically place it on Tier 2 or Tier 3, resulting in a co-pay of $30 to $60 per 30-day supply. Patients who hit their deductible often see costs drop to $10 to $20 per month.

For the uninsured or underinsured, the GoodRx price for Prometrium 200 mg (30 capsules) at Tennessee Walmart pharmacies typically runs $45 to $65 as of mid-2025.